Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge about drug-induced KS, to give guidelines on the correct diagnosis and treatment. This article reviews the literature on drug-induced KS from the last 5 years. Antibiotics and NSAIDs are the most frequently implicated drugs. In addition, data on pathophysiology, clinical presentation, diagnosis, and management are reviewed in detail. Highlight that there is a great deal of variability in the diagnosis and especially in the treatment of KS. This review provides a valuable selection of practical resources for all stakeholders to support effective care for KS, from a cardiologic and allergologic point of view. Future research should focus on developing validated, evidence-based, and patient-centered tools to improve the management of KS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227395 | PMC |
| http://dx.doi.org/10.1007/s40521-023-00342-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Resuscitation of a case of allergy, infarction, and ventricular fibrillation: Kounis syndrome type II and literature review.
Am J Transl Res
December 2024
Department of Emergency Medicine, Yangpu Hospital, School of Medicine, Tongji University Shanghai, China.
To study a case of Kounis syndrome (KS) type II, characterized by allergy, myocardial infarction, and ventricular fibrillation. A patient diagnosed with KS type II was admitted to Yangpu Hospital, School of Medicine, Tongji University in 2021. After systemic treatment, routine investigations, including blood tests, electrocardiography (ECG), and biochemical and coagulation analyses, were performed.
View Article and Find Full Text PDFKounis syndrome manifesting with myocardial infarction due to bi-coronary late stent thrombosis following anaphylaxis.
J Invasive Cardiol
January 2025
Klinikum Fürth, Department of Cardiology and Pneumology, Academic Teaching Hospital of the Friedrich-Alexander-University Erlangen-Nuremberg, Fürth, Germany.
Kounis Syndrome Following Moxifloxacin and Deflazacort Administration.
Eur J Case Rep Intern Med
December 2024
Emergency Department, Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano, Lugano, Switzerland.
Unlabelled: Kounis syndrome (KS), characterized by the simultaneous occurrence of acute coronary syndrome (ACS) and allergic reactions, can be triggered by a range of factors and drugs. We report on the case of a patient who arrived at our emergency department (ED) with symptoms of an allergic reaction after taking moxifloxacin and deflazacort orally. In the ED, the patient experienced a 5-minute episode of oppressive chest pain.
View Article and Find Full Text PDFKounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management.
Hum Vaccin Immunother
December 2024
Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Article Synopsis
- Kounis syndrome is an acute coronary condition triggered by allergic reactions, resulting in heart damage and, in some cases, anaphylactic shock.
- This syndrome can occur as a rare side effect of COVID-19 vaccinations, highlighting the need for further case studies to improve understanding and treatments.
- Analysis of data from 15 patients revealed that the first vaccine dose is more likely to cause Kounis syndrome, emphasizing the importance of prompt diagnosis and monitoring for cardiac symptoms after vaccination.
Subacute Stent Thrombosis Related to Kounis Syndrome During Anaphylaxis Induced by Ultrasound Contrast Agent Infusion.
JACC Case Rep
November 2024
Interventional Cardiology, Careggi University Hospital, Florence, Italy.
Article Synopsis
- A 44-year-old man experienced a severe allergic reaction after receiving SonoVue during a heart test, leading to chest pain and a heart attack caused by stent thrombosis and coronary vasospasm.
- Treatment involved mechanical thrombectomy, stent replacement, and careful management to avoid worsening the patient's condition, ultimately resulting in his recovery and discharge with normal heart function.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!